© 2020 © 2020 Genprex Inc. All Rights Reserved.
Note: When you click on media articles below, a new page will open indicating that you are leaving the Genprex, Inc. website and entering a third-party website not affiliated with Genprex Inc. or any of its affiliates. No information contained in a linked site has been endorsed or approved by Genprex, Inc. and Genprex, Inc. is not responsible for the content of such third-party websites.
Five companies in the past week reported more than $54 million in funding deals and securities offerings.
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual.
How gene therapy is reprogramming the course of lung cancer.
Lead product, Oncoprex, is an injectable treatment for lung cancer.
SPORE Grants Turn Into Hope for Patients.